NCT02803268View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Vasomotor Symptoms
Interventions
DRUG

MT-8554 low dose

DRUG

MT-8554 middle dose

DRUG

MT-8554 high dose

DRUG

Placebo

Trial Locations (1)

Unknown

Investigational center, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY